London midday: Stocks lower on German elections, US debt ceiling
23rd Sep 2013 11:18
Elections in Germany, an uncertain outlook for Federal Reserve monetary policy and a debate over the US debt ceiling weighed on markets on Monday morning, as traders shrugged off upbeat data from China and the Eurozone. The HSBC/Markit flash purchasing managers' index (PMI) for China's manufacturin
Read moreBroker tips: Aberdeen, AG Barr, Henry Boot, Dechra
23rd Sep 2013 11:16
Canaccord Genuity reiterated a 'buy' rating and target price of 440p for Aberdeen Asset Management after the investment company said that underlying profits should still come in at the higher end of analysts' forecasts despite volatile markets in the fourth quarter. "The current dynamics of slowly
Read moreBroker snap: Dechra upgraded to 'buy' on bright outlook, says Investec
23rd Sep 2013 10:08
Veterinary pharmaceuticals group Dechra Pharmaceuticals booked more than a 50 per cent increase in full year revenue, slightly ahead of our expectations, said Investec. Turnover from both continued and discontinued operations climbed from £440m to £522.4m, while underlying pre-tax profit rose from
Read moreMonday broker round-up UPDATE
23rd Sep 2013 09:06
African Barrick Gold: Citi takes target price from 93p to 119p, but still recommends selling. African Minerals: Citi increases target price from 320p to 330p and maintains a buy recommendation. Antofagasta: Citi shifts target price from 780p to 790p, while its sell recommendation remains unchanged
Read moreDechra Pharmaceuticals sees 50 per cent leap in revenue
3rd Sep 2013 14:56
Veterinary pharmaceuticals group Dechra Pharmaceuticals experienced a 'momentous' year with a 52.2 per cent jump in total revenue. Turnover from both continued and discontinued operations climbed from £440m to £522.4m, while underlying pre-tax profit rose from £32.9m to £44.6m. The underlying di
Read moreHalifax chief Nicholson sells 350,000 Lloyds shares
3rd Sep 2013 14:49
The head of Lloyds Banking Group's Halifax arm has sold more than 2.5m pounds of Lloyds shares as the state-backed bank prepares for reprivatisation. David Nicholson disposed of 350,000 shares at 73.34p each on September 2nd for £2.57m. When Nicholson sold his shares, they had gained 120% in the
Read moreTuesday broker round-up
3rd Sep 2013 11:13
ASOS: Exane increases target price from 5000p to 6000p and keeps an outperform rating. Associated British Foods: Exane upgrades to outperform with a target price of 2400p. Balfour Beatty: Berenberg ups target price from 270p to 300p and retains its buy recommendation. Barclays: Berenberg takes ta
Read moreStellar full year at Dechra Pharmaceuticals
3rd Sep 2013 07:15
Veterinary pharmaceuticals firm Dechra Pharmaceuticals posted a robust set of full year results, after a strong performance at its branded pharmaceutical products, and expects progress to continue despite a challenging environment. Profit before tax on continuing operations rose 59.7% (at constant
Read moreFTSE 250 movers: Evraz, Ashtead, Afren, Premier Oil
23rd Aug 2013 14:29
Steel maker Evraz's shares soared after Markit's purchasing managers' index showed China's manufacturing sector hit a four-month high in August as orders rebounded. Ashtead Group gained after UBS reiterated a 'buy' rating for the equipment rental group's stock. Afren declined after the oil explor
Read moreDechra Pharmaceuticals hit by US supply issues, bad weather
10th Jul 2013 10:30
Dechra Pharmaceuticals said adverse weather and supply issues in the US affected trading in the third quarter. In an update for the year to end of June, the veterinary pharmaceuticals company said its US performance was impacted by third party supply issues for the ophthalmic and dermatology ranges
Read moreWednesday broker round-up UPDATE
10th Jul 2013 08:59
Anglo American: Goldman Sachs reduces target price from 1400p to 1100p and retains a sell recommendation. Antofagasta: Goldman Sachs takes target price from 935p to 810p reiterating its neutral rating. Babcock: JP Morgan increases target price from 1230p to 1380p and retains an overweight rating.
Read moreLondon open: Stocks edge higher ahead of FOMC minutes
10th Jul 2013 08:20
The FTSE 100 opened higher on Wednesday morning, though gains were only slight as investors turned cautious ahead of a statement from the Federal Reserve, hoping for indications of when the central bank will begin to taper stimulus. Following the heavy sell-off in June, the strong rebound in market
Read moreFTSE 250 movers: CSR leads the way after Q1 profits soar
8th May 2013 13:31
Consumer electronics company CSR climbed into the top spot on Wednesday after it saw profits soar in the first quarter bolstered by strong sales of wireless products in its auto, and voice and music divisions. Halfords Group was also on the up after JP Morgan raised its target price from 243p to 4
Read moreDechra Pharmaceuticals posts rise in quarterly revenues
8th May 2013 09:10
Dechra Pharmaceuticals reported an increase in revenue in the first three months of the year as a rise in Europe sales offset a fall in the US. Group revenue for its third quarter was up 14.6% ahead of last year, according to a trading update Wednesday. For the nine months ended March 31st, group
Read moreFriday broker round-up UPDATE
22nd Mar 2013 08:48
Afren: Nomura shifts target price from 175p to 180p keeping a neutral rating. ASOS: Nomura increases target price from 2000p to 2630p, while reiterating a neutral rating. Betfair: Panmure Gordon takes target price from 761p to 813p and leaves its buy recommendation unchanged. Brewin Dolphin Holdi
Read more